h3n2v flu strains emerging in usa, page-15

I wonder what the yanks on the board think when PC talks during board meetings.

Possible thought bubbles are:

* why is there a market difference of 7 years between Japan and US for lani - the sales performance in Japan makes it more obvious and painful to the newbies...

* this guy fluffed the RSV program twice

* this guy has driven Vapendavir into a cul de sac

* this guy hasnt done much with antibiotics

In baseball terms, in his very long tenure PC has not once hit the ball outta the ballpark...